FDA approves new tesamorelin formulation by Theratechnologies
Trump team scrambles to handle fallout from Signal chat assailed as 'sloppy, careless'
Fitch places AZEK on positive rating watch amid acquisition by James Hardie
Fitch revises outlook for James Hardie to negative after AZEK acquisition plan
Newsletter
Subscribe to get the latest news, offers and special announcements.


